Hypervirulent Klebsiella pneumoniae defined by a five-gene panel predicts mortality in community-acquired bacteremia
Feng-Yee Chang1, L Kristopher Siu2, Jung-Chung Lin1
1Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.
Objectives:
Experimental models suggest that the combined presence of iucA, iroB, peg-344, rmpA, and rmpA2 reliably distinguishes hypervirulent Klebsiella pneumoniae (hvKp) from classical strains (cKp). We evaluated the clinical relevance of this five-gene definition among adults with K. pneumoniae bacteremia.
Methods:
We performed a longitudinal study in an hvKp-endemic region in adults with community-acquired K. pneumoniae bacteremia. Isolates were classified as hvKp or cKp according to PCR detection of the concurrent presence of five virulence genes. Clinical characteristics and microbiologic features were compared between groups. Predictors of 28-day mortality were identified using logistic regression analysis.
Results:
Among 602 patients, 254 had hvKp bacteremia. hvKp infections were associated with higher rates of abscess formation and longer hospital stays. After adjustment for confounders, hvKp was an independent predictor of 28-day mortality. Most hvKp isolates were susceptible to commonly used antimicrobial agents. The cKp isolates carrying partial combinations of these virulence genes showed clinical and microbiologic characteristics comparable to those lacking all five genes.
Conclusions:
The five-gene hypervirulence profile delineated a clinically more severe subset of K. pneumoniae bacteremia, characterized by higher morbidity and mortality compared with cKp. These findings support the five-gene definition as a robust marker of hvKp in routine practice.
Insights
The five-gene definition accurately identifies hypervirulent Klebsiella pneumoniae (hvKp) bacteremia, a severe infection linked to increased mortality and morbidity. This molecular marker aids in clinical practice for distinguishing hvKp from classical strains.
Area of Science:
- Microbiology
- Infectious Diseases
- Genetics
Background:
- Experimental models indicate five specific genes (iucA, iroB, peg-344, rmpA, rmpA2) differentiate hypervirulent Klebsiella pneumoniae (hvKp) from classical strains (cKp).
- The clinical significance of this five-gene definition in human infections remains to be fully elucidated.
Purpose of the Study:
- To assess the clinical relevance of the five-gene molecular definition for identifying hvKp in adult patients with K. pneumoniae bacteremia.
- To compare clinical characteristics, microbiologic features, and mortality rates between hvKp and cKp infections.
Main Methods:
- A longitudinal study was conducted in an hvKp-endemic region.
- Klebsiella pneumoniae isolates from bacteremic patients were classified as hvKp or cKp based on the presence of the five target virulence genes via PCR.
- Clinical data and outcomes, including 28-day mortality, were analyzed using logistic regression.
Main Results:
- Of 602 patients, 254 had hvKp bacteremia, which was associated with higher rates of abscess formation and prolonged hospital stays.
- hvKp was identified as an independent predictor of 28-day mortality after adjusting for confounders.
- Most hvKp isolates remained susceptible to common antimicrobials, while cKp strains with partial gene combinations showed similar characteristics to those lacking all five genes.
Conclusions:
- The five-gene profile effectively defines a clinically severe subset of K. pneumoniae bacteremia with increased morbidity and mortality.
- This molecular definition serves as a reliable marker for hvKp in clinical settings, aiding in patient management and understanding disease severity.
More Related Videos
06:11Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip
Published on: March 29, 2024
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Atypical Pneumonia
